Targeting both hif1 and hif2 in human colon cancer cells. Among them, tgase 2 was observed in the category of aminoacid metabolism 77. By inhibiting vesseldependent cancer cells, antiangiogenic therapy might be expected to favor cells that overexpress hif1, and lack apoptotic machinery and cell cycle control. Semenza hypoxia inducible factor 1 hif 1 activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion.
N2 hypoxiainducible factor 1 hif1 activates the transcription of genes that are. Targeting both hif1 and hif2 in human colon cancer cells improves tumor response to sunitinib treatment. Hypoxia inducible factor1 hif1 is the main transcriptional activator of the cellular response to hypoxia and an important target of anticancer therapy. Development of inhibitors targeting hypoxiainducible. Download citation targeting hif1 for cancer therapy hypoxiainducible factor 1 hif1 activates the transcription of genes that are involved in crucial. Inhibiting hypoxiainducible factor 1 for cancer therapy. The effects of yc1 on the expression of hypoxiainducible factor 1 alpha hif1. Hif1 is a heterodimeric transcription factor belonging to hifs family which contain three members.
Hypoxiainducible factor 1 hif1 activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion. Targeting the hypoxiainducible factor hif pathway in cancer. Intratumoral hypoxia and genetic alterations can lead to hif 1. Intratumoral hypoxia and genetic alterations can lead to hif1alpha overexpression, which has been.
Hif1 activation, possible general strategies for targeting. Development of inhibitors targeting hypoxiainducible factor 1 and 2 for cancer therapy tianchi yu 1, bo tang, and xueying sun1,2 1department of general surgery, the hepatosplenic surgery center, the. Harris2 and margaret ashcroft1, the central component of hypoxia sensing in the cell is the hypoxiainducible. More than 60 putative direct hif 1 target genes have been identified. Targeting hypoxia and angiogenesis through hif1alpha. The transcriptional factors hif1 and hif2 and their. Mortalinmediated and erkcontrolled targeting of hif1. The potential role of hif on tumour progression and dissemination. Challenges associated with targeting hif1 for cancer therapy lack of specific small molecule inhibitors of hif 1 essential to validate hif 1. Extracellular signalregulated kinase erk is a part of the mitogenactivated protein kinase. Therefore, ape1ref1 downregulation by soy isoflavones could play a central and pivotal role in radiosensitization of prostate cancer cells by affecting hif1. Role of hypoxia in cancer therapy by regulating the tumor.
Combination strategies targeting hypoxia inducible factor. To the extent that ca9 can be considered a specific hypoxiainducible factor 1 hif1 reporter 2,181. Hypoxiaactivated prodrugs in cancer therapy clinical cancer. Request pdf combination strategies targeting hypoxia inducible factor 1 hif 1 for cancer therapy solid tumors often present regions of decreased oxygen levels hypoxia due to an imbalance. Hypoxic cancer cells ccs stimulate blood vessel sprouting. Clinical resistance is a complex phenomenon in major human cancers involving multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular. Hypoxiainducible factor 1 hif1 activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose. Cancer therapy by targeting hypoxiainducible factor1.
Targeting hypoxiainducible factors for antiangiogenic. Interest in the role of hypoxiainducible factor 1 hif1 in cancer biology has grown exponentially in the two decades since its. Semenza hypoxiainducible factor 1 hif1 activates the transcription of genes that are involved in crucial aspects of cancer biology, including. Targeting the hypoxiainducible factor hif pathway in cancer evon poon1, adrian l. Hypoxia is considered a driving force of tumor progression and a negative prognostic factor.
Hypoxiainducible factor1 hif1 is a transcriptional complex that controls cellular and. Summary of clinical trial that are currently recruiting patients targeting. Rcc that is associated with vhl mutations is a good candidate for hif1 targeted therapy. The regulators and effects of hif1 in cancer have intensively provided us a new clue for the hif1 targeting anticancer therapy. Due to its key role in promoting tumor survival and progression under hypoxia, hif1 has become a promising target of. Targeting hypoxia inducible factor 1 hif1 for cancer therapy giovanni melillo developmental therapeutics program, saic frederick inc. Targeting of prostatespecific membrane antigen for radio. Targeting hif1 for cancer therapy johns hopkins university. Hif1 serves as an important regulator in cell response to hypoxia. The inhibitors of hif 1 in cancer have provided us a new clue for the targeting cancer therapy.
Hypoxia inducible factor 1 hif 1 activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion. Development of inhibitors targeting hypoxia inducible factor 1 and 2 for cancer therapy article pdf available in yonsei medical journal 583. Hypoxic cells are more resistant to killing by ionizing radiation and chemotherapy, are more invasive and metastatic. Read overcoming cisplatin resistance of ovarian cancer cells by targeting hif1regulated cancer metabolism, cancer letters on deepdyve, the largest online rental service for scholarly. Triplenegative breast cancer has extremely high risk of relapse due to the lack of targeted therapies, intra and intertumoral heterogeneity, and the inherent and acquired resistance to therapies. Hypoxia has long been recognized as a common feature of solid tumors and a negative prognostic factor for response to treatment and survival of cancer patients. A study in the december 15, 2006 issue of cancer research shows that hif1. Overcoming cisplatin resistance of ovarian cancer cells by. Targeting the hypoxiainducible factor hif pathway in cancer volume 11 evon poon, adrian l. Pdf the discovery of hypoxiainducible factor1 hif1 has led to an increasing understanding of the mechanism of tumor hypoxia in the past. Hypoxiainducible factor 1 as a possible target for cancer. Pdf recent agents targeting hif1 alpha for cancer therapy. Hypoxia low o2 is a pathobiological hallmark of solid cancers, resulting from the imbalance between cellular o2 consumption and availability.
515 1086 1029 1176 723 1420 1483 1237 791 528 1493 719 86 1152 382 1193 1360 106 339 251 1624 947 192 57 1658 285 696 534 468 989 573 596 737